Sonnet BioTherapeutics Granted EU Patent for Innovative FHAB Technology
January 29, 2025 - 11:22
Sonnet BioTherapeutics has successfully obtained a patent from the European Patent Office (EPO) for its groundbreaking fully human albumin binding (FHAB) technology. This significant achievement underscores the company’s commitment to advancing therapeutic solutions that leverage the unique properties of human albumin.
The FHAB technology is designed to enhance the delivery and efficacy of various therapeutic agents, potentially transforming treatment options for patients with a range of medical conditions. By utilizing human albumin, Sonnet aims to improve the pharmacokinetics and bioavailability of drugs, thereby optimizing therapeutic outcomes.
This patent not only strengthens Sonnet's intellectual property portfolio but also positions the company as a leader in the biotherapeutics space. With the growing demand for innovative treatment modalities, the successful patent acquisition is expected to facilitate further research and development initiatives. The company is poised to explore new partnerships and collaborations to maximize the potential of its FHAB technology in the healthcare market.
MORE NEWS
June 9, 2026 - 23:01
Citi Remains Bullish on Seagate Technology (STX)Citi analysts have raised their price target on Seagate Technology Holdings Plc (STX) to $1,150 from $740, while keeping a Buy rating on the stock. The move, announced on June 2, signals strong...
June 9, 2026 - 03:16
You don't need to worry about recursive-self-improving AIAnthropic recently issued a caution about the potential arrival of recursive-self-improving AI, a scenario where artificial intelligence systems autonomously upgrade their own code and capabilities...
June 8, 2026 - 00:17
Will artificial intelligence soon escape human control?The concept of `recursive self-improvement` has long been a staple of science fiction, but it is now a serious topic of debate among researchers and tech executives. The idea is simple yet...
June 7, 2026 - 02:46
Marvell Technology, Flex to join S&P 500 later this monthTwo major technology firms are getting a promotion to the S&P 500 index later this month. Semiconductor company Marvell Technology and electronics manufacturing services provider Flex will both be...